Pfizer Japan Inc. and Eisai Co., Ltd. announced that the companies will commence the co-promotion of the oral calcitonin gene-related peptide (CGRP) receptor antagonist Nurtec OD Tablet 75mg… read more.
NICE (UK): Atogepant can be used as an option for the acute treatment of migraine with or without aura in adults, only if, for previous migraines: i) at… read more.
People diagnosed with early-onset dementia had reduced work productivity up to 15 years before diagnosis, according to a study published July 8, 2026, in Neurology®, the medical journal of… read more.
Eisai Co., Ltd. announced that the United Kingdom’s (U.K.) Medicines and Healthcare products Regulatory Agency (MHRA) has accepted for evaluation a marketing authorization application (MAA) for its in-house-discovered… read more.
New research using smartwatches shows that older adults can accurately assess how well they are thinking in the moment. The study finds their self-ratings closely match actual cognitive… read more.
Waking up from surgery feeling nauseous or vomiting is one of the most distressing experiences a patient can have — and one that patients consistently rank as worse… read more.
Johnson & Johnson announced publication of the primary results from the MEMBRANE randomized controlled trial in JAMA Neurology. The study showed that adding middle meningeal artery embolization (MMAe)… read more.
Novocure announced topline results from its Phase 3 TRIDENT trial, which evaluated the initiation of Tumor Treating Fields (TTFields) therapy for newly diagnosed glioblastoma (GBM) at the start… read more.
Lundbeck A/S today announced that new migraine clinical data will be presented at the European Academy of Neurology (EAN) Congress 2026, taking place 27–30 June in Geneva, Switzerland…. read more.
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced 11 late-breaking presentations at SLEEP 2026, including notable new research showcasing the comprehensive treatment outcomes of Xywav® (calcium, magnesium, potassium, and sodium… read more.
Shingles vaccination reduces dementia risk, researchers reported on June 15, 2026 in the Annals of Internal Medicine. “Receipt of RZV [recombinant shingles vaccine] during admission to a skilled-nursing… read more.
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new clinician-reported data in patients with intellectual and developmental disabilities demonstrating meaningful and rapid improvements in tardive dyskinesia severity, as well as improvements… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
